Samsara BioCapital, LLC

Holdings History for AEGLEA BIOTHERAPEUTICS INC - COM (AGLE)

Symbol: AGLE
Investment type: Equity / COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2023		-0.07%	$0	0	-883,720	-100%		Q3 2023
30 Jun 2023	0.07%	0%	$398,116	883,720	0		$0.45	Q2 2023
31 Mar 2023	0.05%	0%	$256,279	883,720	0		$0.29	Q1 2023
31 Dec 2022	0.09%	0%	$397,586	883,720	0		$0.45	Q4 2022
30 Sep 2022	0.11%	0%	$465,000	883,720	0		$0.53	Q3 2022
30 Jun 2022	0.12%	0%	$446,000	883,720	0		$0.50	Q2 2022
31 Mar 2022	0.51%	0%	$2,033,000	883,720	0		$2.30	Q1 2022
31 Dec 2021	0.84%	0%	$4,198,000	883,720	0		$4.75	Q4 2021
30 Sep 2021	1.2%	0%	$7,026,000	883,720	0		$7.95	Q3 2021
30 Jun 2021	0.81%	0%	$6,151,000	883,720	0		$6.96	Q2 2021
31 Mar 2021	1.4%	0%	$6,999,000	883,720	0		$7.92	Q1 2021
31 Dec 2020	1.4%	0%	$6,955,000	883,720	0		$7.87	Q4 2020
30 Sep 2020	1.7%	-0.17%	$6,266,000	883,720	-83,780	-8.7%	$7.09	Q3 2020
30 Jun 2020	2.9%	+2.9%	$8,949,000	967,500	+967,500	NEW	$9.25	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.